What is the economic case for treating obesity?

Area of Science:

• Public Health
• Health Economics
• Obesity Research

Background:

• Obesity represents a substantial economic burden in the United States, accounting for approximately 6% of national health expenditure.
• Physician visits related to obesity have surged by 88% over a six-year period.
• Morbidity costs associated with obesity, including lost productivity and reduced functional capacity, are escalating rapidly.

Purpose of the Study:

• To highlight the significant economic impact of obesity in the United States.
• To compare the economic burden and potential cost savings of obesity treatment with other chronic diseases.
• To underscore the lack of published cost-effectiveness studies for medical obesity management.

Main Methods:

• Review of economic data related to obesity prevalence and healthcare costs.
• Analysis of trends in physician visits and morbidity associated with obesity.
• Comparative analysis of cost savings from obesity treatment versus other chronic conditions.

Main Results:

• The economic effect of obesity is substantial, impacting national health expenditure and healthcare costs.
• Obesity treatment cost savings are comparable to those for coronary heart disease and diabetes.
• Direct healthcare costs are primarily linked to type 2 diabetes, coronary heart disease, and hypertension in patients with obesity.

Conclusions:

• Obesity's economic impact is comparable to other major chronic diseases but receives less attention.
• There is a critical need for prompt initiation of cost-effectiveness studies for medical obesity treatment.
• Further research into the economic implications and management strategies for obesity is warranted.